OrganOx metra®

The World’s First Normothermic Machine Perfusion (NMP) Platform

This Changes Everything.

OrganOx metra normothermic machine perfusion (NMP) device for liver transplant procedures.

OrganOx metra® has already changed transplantation for the liver.1

Now, it’s the foundation of a platform that aims to transform the entire field of organ technology.

Every Organ is a Life-Saving Opportunity

The OrganOx metra platform extends organ preservation time,2 giving clinicians a longer window and more options to make better use of donor pools. Extending the length of time an organ is perfused enables clinicians to perform a more in-depth functional assessment on it, which can help lead to better outcomes.

OrganOx metra can help

Lower organ discard rates3,4
Close-up of two hands gently holding each other, symbolizing care and support in a healthcare setting.
Make more
organs available for transplant3,4
Smiling couple outdoors under bright sunlight, standing in front of a white architectural wall.
Shorten transplant wait lists5
Smiling couple standing together in an elegant building lobby with suitcases, looking upward, representing lives positively impacted by successful organ transplant procedures.
Enable better planning for safer surgeries5
Transplant surgical team in scrubs and masks operating under bright surgical lights in a modern operating room.

More Time. More Options. More Hope.

OrganOx metra can provide transplant teams with the time they need to confidently make individual decisions for each organ and recipient, along with the flexibility to perform surgery when all involved are best prepared for success. OrganOx metra is built on NMP technology that has been shown by clinical evidence to support better outcomes.

Increases overall transplant volume by 20%5
Allows surgeries to be planned and pre-scheduled instead of urgent procedures
Enables surgeons to more confidently assess and accept more marginal organs3,4
Reduces discard rates up to 50% reduction vs. static cold storage7
Lowers graft injury by 50% (as measured by hepatocellular enzyme release)7
Empowers transplant centers with more clinical oversight, participation, and control throughout the entire workflow

OrganOx metra for Liver

With its multiple advanced automation features, our flagship product maintains perfusion conditions with an ease, consistency, and predictability that frees transplant surgeons to focus on the surgery itself.

OrganOx metra normothermic machine perfusion (NMP) device for liver transplant procedures.

How It Works

With the OrganOx metra, the donor liver is continuously perfused with oxygenated blood-based perfusate, medications, and nutrients at normal body temperature and near-physiological pressures and flows. Keeping the liver functional throughout preservation enables a more informed and accurate assessment of its viability for transplant.

test

Centrifugal Pump

A centrifugal pump draws blood from the liver, intelligently adjusting to physiological changes to ensure optimal perfusion.

test

Oxygenator

A self-regulating oxygenator receives oxygen that has been concentrated from ambient air, which it transfers into the blood-based perfusate while it is warmed by an on-board heater.

test

Perfusate Reservoir

A soft-shell reservoir stores the warm, oxygenated blood-based perfusate and supplies it to the liver under near-physiological pressure.

test

Blood Gas Analyzer

In-line blood gas analysis provides real-time monitoring of pO2, pCO2, pH and temperature.

test

Medication Infusion Driver

A syringe infusion driver delivers insulin, heparin, bile salts and epoprostenol. Infusions are delivered automatically, at a fixed rate, to provide continuous infusion throughout and help minimize the operator’s hands-on time.

test

Nutrition Pump

A mini roller pump can deliver a nutrition solution, or TPN, in response to user-measured glucose values.

test

Touchscreen

An easy-to-use touchscreen provides real-time pO2, pCO2, pH values and other perfusion information at a glance throughout the procedure.

Explore OrganOx metra
Our last run of metra transplants was very satisfying – we were able to transplant livers rejected by all US programs that definitely could not have been used otherwise.”

Professor James Shapiro

University of Alberta, Edmonton, Canada

The Future of Organ Technology Starts Here

OrganOx metra is approved for use in liver transplants across Europe, the United States, Canada, and Australia, and its safety and effectiveness is supported by ample clinical evidence.3,6,7

OrganOx metra has already supported the transplantation of over 5,000 livers worldwide, and that number continues to grow as its availability rapidly expands into new markets.

Get in Touch
Microscopic image of simple cuboidal epithelium tissue showing pink-stained cells arranged in tubular structures.
  1. Ravikumar, R., Jassem, W., Mergental, H., Heaton, N., Mirza, D., Perera, M. T. P. R., & Friend, P. J. (2016). Liver transplantation after ex vivo normothermic machine preservation: A phase 1 (first-in-man) clinical trial. American Journal of Transplantation, 16(6), 1779–1787. https://doi.org/10.1111/ajt.13741.
  2. OrganOx Ltd. (2024). OrganOx® metra® instructions for use (USA version, Rev05). OrganOx Ltd. https://sites.google.com/view/2tyshpvxatbpbjgs7bff6bs7nturpw/na-ifu?authuser=0
  3. Mergental, H., Laing, R. W., Kirkham, A. J., Perera, M. T. P. R., Boteon, Y. L., Attard, J., Barton, D., Curbishley, S., Wilkhu, M., Neil, D. A. H., Hübscher, S. G., Muiesan, P., Isaac, J. R., Roberts, K. J., Abradelo, M., Schlegel, A., Ferguson, J., Cilliers, H., Bion, J., Adams, D. H., … Mirza, D. F. (2020). Transplantation of discarded livers following viability testing with normothermic machine perfusion. Nature communications, 11(1), 2939. https://doi.org/10.1038/s41467-020-16251-3
  4. Olumba, F. C., Zhou, F., Park, Y., Chapman, W. C., & RESTORE Investigators Group (2023). Normothermic Machine Perfusion for Declined Livers: A Strategy to Rescue Marginal Livers for Transplantation. Journal of the American College of Surgeons, 236(4), 614–625. https://doi.org/10.1097/XCS.0000000000000555
  5. Wehrle, C. J., Hong, H., Gross, A., Liu, Q., Ali, K., Cazzaniga, B., Miyazaki, Y., Tuul, M., Modaresi Esfeh, J., Khalil, M., Pita, A., Fernandes, E., Kim, J., Diago-Uso, T., Aucejo, F., Kwon, D. C. H., Fujiki, M., Quintini, C., Schlegel, A., Pinna, A., … Hashimoto, K. (2024). The impact of normothermic machine perfusion and acuity circles on waitlist time, mortality, and cost in liver transplantation: A multicenter experience. Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 10.1097/LVT.0000000000000412. Advance online publication. https://doi.org/10.1097/LVT.0000000000000412.
  6. Wehrle, C. J., Zhang, M., Khalil, M., Pita, A., Modaresi Esfeh, J., Diago-Uso, T., Kim, J., Aucejo, F., Kwon, D. C. H., Ali, K., Cazzaniga, B., Miyazaki, Y., Liu, Q., Fares, S., Hong, H., Tuul, M., Jiao, C., Sun, K., Fairchild, R. L., Quintini, C., … Schlegel, A. (2024). Impact of Back-to-Base Normothermic Machine Perfusion on Complications and Costs: A Multicenter, Real-World Risk-Matched Analysis. Annals of surgery, 280(2), 300–310. https://doi.org/10.1097/SLA.0000000000006291
  7. Nasralla, D., Coussios, C. C., Mergental, H., Akhtar, M. Z., Butler, A. J., Ceresa, C. D. L., Chiocchia, V., Dutton, S. J., García-Valdecasas, J. C., Heaton, N., Imber, C., Jassem, W., Jochmans, I., Karani, J., Knight, S. R., Kocabayoglu, P., Malagò, M., Mirza, D., Morris, P. J., Pallan, A., … Consortium for Organ Preservation in Europe (2018). A randomized trial of normothermic preservation in liver transplantation. Nature, 557(7703), 50–56. https://doi.org/10.1038/s41586-018-0047-9